40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ming-Yuan Chen, MD,PhD
Sun Yat-sen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Provincial Cancer Hospital
Hefei, Anhui, China
Recruiting - Fujian Cancer Hospital
Fuzhou, Fujian, China
Recruiting - Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - the Affiliated Cancer Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Recruiting - Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China
Recruiting - Zhongshan City People'S Hospital
Zhongshan, Guangdong, China
Recruiting - the Fifth Affiliated Hospital of Sun Yat-Sen University
Zhuhai, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China
Recruiting - Wuzhou Red Cross Hospital
Wuzhou, Guangxi, China
Recruiting - Central South University Cancer Hospital,
Changsha, Hunan, China
Recruiting - Xiangya Hospital of Central South University
Changsha, Hunan, China
Recruiting - West China Hospital, Sichuan University
Chengdu, Sichuan, China
Recruiting - the First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Recruiting - Yunnan Cancer Hospital
Kunming, Yunnan, China
Recruiting - Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Nov 2025
- Primary completion
- 30 Jun 2030
- Completion
- 30 Jun 2032
- Last update posted
- 9 Jan 2026
- Registered enrollment
- 346
- Registry id
- NCT07328854
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.